arrow
Back
B

Biontech Se

Scholars673
Papers236
Citations7
Related Papers (233)
Publication Date
Chemically synthesized, non-capped and non-polyadenylated peptide-coding RNA efficiently induces antigen-specific CD8+ T cells
err2026-07-07
err0
errOAAI
errJulia Frei; David Eisel; Natalia Teresa Jarzebska; Mark Mellett; Ikra Gizem Yener; Marie Therese Abdou; Cécile Gouttefangeas; Lukas Flatz; Mustafa Diken; Thomas M. Kündig; Ugur Sahin; Steve Pascolo
errShare
errSave
Safety and immunogenicity of BNT162b2 in ART-treated PWH
err2026-06-21
err0
errOAAI
errEssack Mitha; Mezgebe Berhe; Judith Aberg; Christopher J Lucasti; Fadi Chalhoub; Nicholas Kitchin; Isabel Vogler; Stephen P Lockhart; Sina Fuchs; Jasmin Quandt; William C Gruber; Chris Webber; Marie-Cristine Kühnle; Alexander Muik; Bonny Gaby Lui; Maria J G T Vehreschild; Christoph Stephan; Meghan Bushway; Xia Xu; Todd J Belanger; James Trammel Price; Stefan Liebscher; Ruth Bailey; Susan Mather; Elizabeth M Adams; Svetlana Shpyro; Eleni Lagkadinou; Özlem Türeci; Kena A Swanson; Uğur Şahin; Alejandra Gurtman; null
errShare
errSave
mRNA-based tuberculosis vaccines BNT164a1 and BNT164b1 are immunogenic, well tolerated and efficacious in rodent models
err2026-06-12
err0
errOAAI
errNeha Agrawal; Louis S. Ates; Stefan A. Schille; Anuhar Chaturvedi; Janina Vogt; Natasa Vukovic; Charles L. Dulberger; Annette B. Vogel; Jan Diekmann; Mustafa Diken; Uğur Şahin
errShare
errSave
PP01.123: A Global Phase 3, Double-Blind, Randomized Trial of Pumitamig (BNT327/BMS986545; PD-L1 × VEGF-A bsAb) Plus Chemotherapy Compared to Atezolizumab Plus Chemotherapy in Patients with First-Line (1L) Extensive-Stage Small Cell Lung Cancer (ES-SCLC) - ROSETTA Lung-01
err2026-05-07
err0
PREAI
errMartin Reck; John Heymach; Kevin Franks; Carl Gay; Vinod Ganju; Ina Nordman; Nicolas Girard; Mehmet Ali Nahit Sendur; Ilhan Celik; Isaac Dai; Secil Koseoglu; Sarita Koride; Karrie Wang; Silke Günther; Özlem Türeci; Ugur Sahin
errShare
errSave
PP01.58: A Global Phase 2/3, Randomized, Open-Label Trial of Pumitamig (BNT327/BMS986545; PD-L1 × VEGF-A bsAb) in Combination with Chemotherapy in First-Line (1L) Non-Small Cell Lung Cancer (NSCLC) – ROSETTA Lung-02
err2026-05-07
err0
PREAI
errSolange Peters; Stephen V. Liu; Vinod Ganju; Suzanne Kosmider; Se-Hoon Lee; Mehmet Ali Nahit Sendur; Yvonne Summers; Nicolas Girard; Yotsawaj Runglodvatana; Bouchaab Hasna; Ilhan Celik; Ulug Gunaydin; René Bartz; Sarita Koride; Li Li; Claudia-Nanette Gann; Ugur Sahin; Özlem Türeci; Shun Lu
errShare
errSave
AHEAD-MERIT: A Phase II/III Trial of First Line (1L) BNT113 Plus Pembrolizumab in Unresectable Recurrent or Metastatic HPV16+ HNSCC
err2026-04-16
err0
PREAI
errN.F. Saba; K. Klinghammer; C. Ottensmeier; S. Tillmanns; U. Tschiesner; H. Yang; R. Das; R. Oseni; Ö. Türeci; U. Şahin
errShare
errSave
Gotistobart or docetaxel in metastatic squamous non-small cell lung cancer: stage 1 of the randomized phase 3 PRESERVE-003 trial
err2026-03-27
err0
errOAAI
errByoung Chul Cho; Rama Balaraman; Hua-Jun Chen; Xinmin Yu; Adewale Fawole; Zhi-gang Liu; Jiliang Zhang; Long Wu; Bin Yang; Jennifer L. Leddon; John Hamm; Yanjing Huang; Lin Wu; Pinhua Pan; Preet Singh; Andrew Beardsley; Fadi Kayali; Ardalan Davarifar; Ki Hyeong Lee; Keon-Uk Park; Youngjoo Lee; Luchun Li; Xicheng Wang; Meili Sun; Yan Yu; Vikram Jain; Svetlana Shpyro; Qiong Wang; Michael Wenger; Uğur Şahin; Sergey Efuni; Shiling Song; Kun He; Pan Zheng; Yang Liu; Kai He; Tianhong Li; Mark A. Socinski; Yi-Long Wu
errShare
errSave
Safety and Immunogenicity of a Fourth Dose of Omicron BA.1-Adapted BNT162b2 COVID-19 Vaccines in Adults 18-55 Years Old
err2026-02-01
err0
PREAI
errWinokur, Patricia; Diya, Oyeniyi; Fitz-Patrick, David; Dever, Michael; Gayed, Juleen; Lockhart, Stephen; Xu, Xia; Zhang, Ying; Bangad, Vishva; Wadsworth, L. Tyler; Cannon, Kevin; Cardona, Jose F.; Usdan, Lisa; Ginis, John; Mensa, Federico J.; Zou, Jing; Xie, Xuping; Lu, Claire; Buitrago, Sandra; Scully, Ingrid L.; Cooper, David; Koury, Kenneth; Jansen, Kathrin U.; Tureci, Ozlem; Sahin, Ugur; Swanson, Kena A.; Gruber, William C.; Kitchin, Nicholas
errShare
errSave
Strong and early immune responses against SARS-CoV-2 in mice and rhesus macaques after BNT162b3 vaccination
err2026-01-13
err0
errOAAI
errVogel, Annette B.; Lui, Bonny G.; Tompkins, Kristin; Kanevsky, Isis; Muik, Alexander; Krumm, Stefanie A.; Gueler, Alptekin; Maddur, Mohan S.; Walzer, Kerstin C.; Witzel, Sonja; Vascotto, Fulvia; Stanganello, Eliana; Ota-Setlik, Ayuko; Cottingham, Kimberly J.; Allbritton, Omaira; Keverne, Jessica; Aragao-Santiago, Leticia; Swanson, Kena A.; Tureci, Ozlem; Sahin, Ugur
errShare
errSave
CoV-UniBind: a unified antibody binding database for SARS-CoV-2
err2026-01-01
err0
PREAI
errBhasin, Aryan; Saccon, Francesco; Canavan, Callum; Robson, Andrew; Euko, Joao; Walls, Alexandra C.; Fu, Yunguan
errShare
errSave
T-cell Response Induced by the BNT162b2 COVID-19 Vaccine in Children
err2025-12-01
err0
errOAAI
errVogler, Isabel; Renken, Stephanie; Hilker, Rolf; Lui, Bonny Gaby; Finlayson, Andrew; Gurtman, Alejandra; Sabharwal, Charulata; Kitchin, Nicholas; Lockhart, Stephen; Gruber, William C.; Jansen, Kathrin U.; Swanson, Kena A.; Tureci, Ozlem; Sahin, Ugur
errShare
errSave
errShare
errSave
Stable and Predictable Lentiviral Vector Production at Clinical Scale
err2025-11-01
err0
PREAI
errHeinz, Niels; Mosbacher, Laura; Cordie, Lisa C.; Zeller, Katharina; Rohn, Florian; Naeher, Melanie; Hien, Melina; Ohlinger, Stefan; Kuehlcke, Klaus; Loew, Rainer
errShare
errSave
Risk of Severe Outcomes From COVID-19 in Immunocompromised People During the Omicron Era: A Systematic Review and Meta-Analysis
err2025-08-23
err0
errOAAI
errAkvile Chapman; Francis Berenbaum; Giuseppe Curigliano; Triantafyllos Pliakas; Aziz Sheikh; Sultan Abduljawad
errShare
errSave
Risk of severe outcomes from COVID-19 in comorbid populations in the Omicron era: A systematic review and meta-analysis
err2025-06-24
err0
errOAAI
errAkvile Chapman; Dan H. Barouch; Gregory Y.H. Lip; Triantafyllos Pliakas; Eva Polverino; Harald Sourij; Sultan Abduljawad
errShare
errSave
Acasunlimab, an Fc-inert PD-L1x4-1BB bispecific antibody, combined with PD-1 blockade potentiates antitumor immunity via complementary immune modulatory effects
err2025-04-10
err0
PREAI
errCapello, Michela; Sette, Angelica; Plantinga, Theo; Thalhauser, Craig J.; Spires, Vanessa M.; Nuermberger, Kristina B.; Blum, Jordan M.; Higgs, Brandon W.; Garrido Castro, Patricia; Yu, Christina; Costa Sa, Carol; Fellermeier-Kopf, Sina; Burm, Saskia M.; Strumane, Kristin; Toker, Aras; Imle, Andrea; de Andrade Pereira, Bruna; Muik, Alexander; Ahmadi, Tahamtan; Tuereci, Oezlem; Fereshteh, Mark; Sahin, Ugur; Jure-Kunkel, Maria; Pencheva, Nora
errShare
errSave
Nanoparticle platform preferentially targeting liver sinusoidal endothelial cells induces tolerance in CD4+T cell-mediated disease models
err2025-03-17
err0
errOAAI
errWang, Shu-Hung; Serr, Isabelle; Digigow, Reinaldo; Metzler, Barbara; Surnov, Alexey; Gottwick, Cornelia; Alsamman, Muhammad; Krzikalla, Daria; Heine, Markus; Zahlten, Miriam; Widera, Agata; Mungalpara, Disha; Seleci, Muharrem; Fanzutti, Marco; Mesquita, Ligia Margarida Marques; Vocaturo, Anna-Lisa; Herkel, Johannes; Carambia, Antonella; Schroeter, Christian; Sarko, Dikran; Pohlner, Johannes; Daniel, Carolin; de Min, Cristina; Fleischer, Sabine
errShare
errSave
The Chimeric Antigen Receptor T Cell Target Claudin 6 Is a Marker for Early Organ-Specific Epithelial Progenitors and Is Expressed in Some Pediatric Solid Tumor Entities
errCANCERS
IF4.4
err2025-03-07
err0
errOAAI
errSeidmann, Larissa; Wingerter, Arthur; Metzig, Marie Oliver; Bornas, Angelina; El Malki, Khalifa; Ustjanzew, Arsenij; Ortmueller, Franziska; Kamyshanskiy, Yevgeniy; Kindler, Thomas; Laible, Mark; Mohr, Xenia; Henninger, Nicole; Russo, Alexandra; Beck, Olaf; Alt, Francesca; Wehling, Pia; Roth, Wilfried; Paret, Claudia; Faber, Joerg
errShare
errSave
Editorial: The immune response to therapeutic antibodies
err2025-02-10
err0
errOAAI
errTovey, Michael G.; Kromminga, Arno J.; Mytych, Daniel T.
errShare
errSave
Safety and Immunogenicity of Concomitant Administration and Combined Administration of Bivalent BNT162b2 COVID-19 Vaccine and Bivalent RSVpreF Respiratory Syncytial Virus Vaccine with or Without Quadrivalent Influenza Vaccine in Adults ≥ 65 Years of Age
err2025-02-05
err0
errOAAI
errNeutel, Joel M.; Erdem, Rahsan; Jiang, Qin; Cannon, Kevin; Stacey, Helen; Newton, Ryan; Gomme, Emily; Li, Wen; Mensa, Federico J.; Tureci, Ozlem; Sahin, Ugur; Swanson, Kena A.; Munjal, Iona; Cooper, David; Koury, Kenneth; Anderson, Annaliesa S.; Gurtman, Alejandra; Kitchin, Nicholas
errShare
errSave